Differential expression of microRNAs as predictors of glioblastoma phenotypes

BMC Bioinformatics

Volumn 15, Issue 1, 2014, Pages

  Bradley, Barrie S ^a   Loftus, Joseph C ^b   Mielke, Clinton J ^a   Dinu, Valentin ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cell migration; Gene expression; Glioblastoma; MicroRNA; miR; Pathway analysis; Target prediction

Indexed keywords

CELL MIGRATION; GLIOBLASTOMAS; MICRORNAS; MIR; PATHWAY ANALYSIS; TARGET PREDICTION;

BIOINFORMATICS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; DIAGNOSIS; DIGITAL STORAGE; RNA; TUMORS;

GENE EXPRESSION;

MICRORNA;

APOPTOSIS; ARTICLE; BIOLOGY; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; METHODOLOGY; PHENOTYPE; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PHENOTYPE;

EID: 84892455527     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-15-21     Document Type: Article

References (32)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10(5):459-466. 10.1016/S1470-2045(09)70025-7, 19269895.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996. 10.1056/NEJMoa043330, 15758009.
3. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005, 7(1):7-16. 10.1593/neo.04535, 1490313, 15720813.
4. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, et al. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 2001, 53(2):161-176. 10.1023/A:1012253317934, 11716068.
5. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, Nakada S, Anderson EM, Henrichs AN, McDonough WS, et al. Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 2008, 9:54. 10.1186/1471-2164-9-54, 2275271, 18230158.
6. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, Berens ME. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 2003, 116(Pt 21):4409-4417.
7. Liu N, Okamura K, Tyler DM, Phillips MD, Chung WJ, Lai EC. The evolution and functional diversification of animal microRNA genes. Cell Res 2008, 18(10):985-996. 10.1038/cr.2008.278, 2712117, 18711447.
8. Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011, 585(13):2087-2099. 10.1016/j.febslet.2010.08.009, 20708002.
9. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334(4):1351-1358. 10.1016/j.bbrc.2005.07.030, 16039986.
10. Lawler S, Chiocca EA. Emerging functions of microRNAs in glioblastoma. J Neurooncol 2009, 92(3):297-306. 10.1007/s11060-009-9843-2, 19357957.
11. Novakova J, Slaby O, Vyzula R, Michalek J. MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 2009, 386(1):1-5. 10.1016/j.bbrc.2009.06.034, 19523920.
12. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez G, Bautista-Pina V, Arellano-Llamas R, Hidalgo-Miranda A. Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PloS One 2012, 7(3):e31904. 10.1371/journal.pone.0031904, 3306365, 22438871.
13. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25(15):1991-1993. 10.1093/bioinformatics/btp299, 19435746.
14. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403(6772):901-906. 10.1038/35002607, 10706289.
15. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408(6808):86-89. 10.1038/35040556, 11081512.
16. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol 2008, 18(10):505-516. 10.1016/j.tcb.2008.07.007, 18774294.
17. Wang X, Cao L, Wang Y, Wang X, Liu N, You Y. Regulation of let-7 and its target oncogenes (Review). Oncol Lett 2012, 3(5):955-960. 3389667, 22783372.
18. Lee ST, Chu K, Oh HJ, Im WS, Lim JY, Kim SK, Park CK, Jung KH, Lee SK, Kim M, et al. Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol 2011, 102(1):19-24. 10.1007/s11060-010-0286-6, 20607356.
19. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005, 120(5):635-647. 10.1016/j.cell.2005.01.014, 15766527.
20. Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A, Tatsumi T, Ishida H, Noda T, Nagano H, et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010, 52(5):698-704. 10.1016/j.jhep.2009.12.024, 20347499.
21. Soni D, King JA, Kaye AH, Hovens CM. Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge. J Clin Neurosci 2005, 12(1):1-5. 10.1016/j.jocn.2004.04.001, 15639402.
22. Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, Flaegstad T, Einvik C. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 2011, 105(2):296-303. 10.1038/bjc.2011.220, 3142803, 21654684.
23. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 2008, 1236:185-193.
24. Zhu W, Shan X, Wang T, Shu Y, Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010, 127(11):2520-2529. 10.1002/ijc.25260, 20162574.
25. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008, 123(2):372-379. 10.1002/ijc.23501, 18449891.
26. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004, 145(12):5439-5447. 10.1210/en.2004-0959, 15331580.
27. Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL, Dong Y, Hou L, Hu G, Luo C, et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 2012, 106(3):473-484. 10.1007/s11060-011-0692-4, 21912938.
28. Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D, Foo J, Subramanian S, Steer CJ. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol 2012, 9(10):1275-1287. 10.4161/rna.21998, 3583858, 22995834.
29. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008, 14(11):1271-1277. 10.1038/nm.1880, 18931683.
30. Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S, Sun C, Ma M, Huang Y, Xi JJ. Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2011, 2:554.
31. Pellegrino L, Stebbing J, Braga VM, Frampton AE, Jacob J, Buluwela L, Jiao LR, Periyasamy M, Madsen CD, Caley MP, et al. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res 2013, 41(10):5400-5412. 10.1093/nar/gkt245, 3664824, 23580553.
32. Loftus JC, Ross JT, Paquette KM, Paulino VM, Nasser S, Yang Z, Kloss J, Kim S, Berens ME, Tran NL. miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. PloS One 2012, 7(6):e39818. 10.1371/journal.pone.0039818, 3382150, 22745829.